Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
December 20, 2020

The Impact of COVID-19 on Melanoma Patients

Career Development Award – Rebecca Hartman, MD, MPH

1 Minute Read
December 20, 2020

CXCL9 as an Immune Anti-Melanoma Therapy in Combin...

A major obstacle to even the best melanoma therapies is that in the majority of cases, the tumor never completely goes away. Even if a little bit remains, called the minima...

3 Minute Read
December 20, 2020

Identification of Metastatic Modulators through Ze...

Melanomas arise from pigmented cells called melanocytes, typically in the skin. Melanomas can spread to distal parts of the body, through a process called metastasis. Metas...

3 Minute Read
December 20, 2020

Elucidating Metabolic Changes that Occur in Melano...

Melanoma is the third most common malignancy to metastasize to the brain. It is estimated that at least 50% of patients with stage IV melanoma will develop brain metastases...

2 Minute Read
December 20, 2020

Defining the Mechanisms of Resistance to Anti-CTLA...

Over the past decade, harnessing the power of a patient’s own immune system for the treatment of cancer has been a major medical breakthrough. By using drugs to block inh...

2 Minute Read
December 20, 2020

Converting Regulatory into Proinflammatory Anti-Tu...

The majority of cancer patients do not yet benefit from immunotherapy, including from immune checkpoint therapies that invigorate the patients’ own immune systems to figh...

2 Minute Read
December 20, 2020

Novel Target for Melanoma Therapeutic Development

Melanoma is one of the fastest growing malignancies and accounts for 5.5% of all new cancer cases in the United States. Treatment options and prognosis of melanoma patients...

2 Minute Read
December 20, 2020

Integrative Analysis of Prognostic Factors to Neoa...

Patients with lymph-node positive melanoma have a high risk of recurrence despite curative surgery. While adjuvant therapy given after surgery improves RFS and OS, ~25% of ...

1 Minute Read
December 23, 2019

Geographic Analysis of Indoor Tanning Salon Cluste...

Medical Student Award – Rebecca Chen

1 Minute Read
December 23, 2019

Evaluating the Role of the COX2/PGE2 Pathway in An...

Medical Student Award – Michelle Ferreira

1 Minute Read
December 23, 2019

Determining Mechanisms of Enhanced Anti-Tumor Effi...

Medical Student Award – Hannah Knochelmann

1 Minute Read
December 23, 2019

Understanding Skin Rash Secondary to Checkpoint In...

Medical Student Award – Cory Kosche

1 Minute Read

Oct 04, 2025 ET

Seattle Miles for Melanoma 5K

Oct 05, 2025 ET

Los Angeles Miles for Melanoma 5K

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Explore Events